Market Research Reports

Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and Others) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022

112pages
Published Date: 2015-05-21

Description


 

Over the decade, the global non-invasive prenatal testing (NIPT) has shown a healthy growth. The rise in the global average of maternal age, coupled with the increasing incidence of Down syndrome in newborns, has boosted the market to a significant level. Additionally, the augmenting demand for timely and non-invasive fetal diagnosis is anticipated to propel the market in the coming years.

The global NIPT market is analyzed on the basis of the tests and the regional distribution of this market. Based on tests, the market is broadly classified into BambniTest, informaSeq, Harmony, MaterniT21 PLUS, Panorama, NIFTY, PrenaTest, VisibiliT, and verifi. Regionally, the worldwide market for NIPT is distributed among North America, Asia Pacific, Europe, and the Rest of the World.

The report present a comprehensive study of the global NIPT market with an analytical approach. Market drivers, restraints, opportunities, current and upcoming trends, and various segmentations of this market has been discussed at length in this study, making it a valuable source of guidance for market participants.

Overview of the Global NIPT Market

The global NIPT market stood at US$0.5 bn in 2013. Expanding at a CAGR of 17.50% over the period from 2014 to 2022, the market is projected to reach US$2.38 bn by the end of the forecast period.

According to the report, the first non-invasive prenatal test launched in the market was MaterniT21 PLUS. The test was introduced in 2011 and was intended to diagnose trisomy 21. In 2013, the market for MaterniT21 PLUS accounted for 36.1% of the total revenue generated in the NIPT market across the globe. However, this market segment is likely to lose ground on account of rising commercialization of panorama, Verifi, Bambni, and NIFTY during the forecast period. 

The NIPT market in North America emerged as the largest regional market of the global NIPT market in 2013 with a 58.8% share in terms of revenue and a 51% share in terms of volume. The presence of major market participants in the U.S. and a high level of awareness pertaining to NIPT in North America has boosted the regional market extensively.

The Asia Pacific NIPT market is showing immense potential for growth. Australia, Japan, India, and China are the key markets for NIPT in this region. A large population base of women choosing late pregnancy is expected to drive the Asia Pacific market for NIPT market over the forecast period.

The presence of untapped opportunities in developing economies across the globe provides a huge potential market for participants. However, the strict regulatory guidelines regarding non-invasive prenatal testing and the availability of alternative screening and testing procedures are likely inhibit the growth of the market to an extent.

Companies mentioned in the research report

Laboratory Corporation of America Holdings, Berry Genomics Co. Ltd., Illumina Inc., LifeCodexx AG, Sequenom Inc., BGI Diagnostics, Ariosa Diagnostics Inc., and Natera Inc. are the major companies functioning in the global NIPT market. Strategic partnership and alliance with hospitals, medical research centers, and clinical laboratories are the key trends among the market participants for the expansion of their business.

Key segments of the Global NIPT Market

By Test

  • BambniTest
  • Harmony
  • informaSeq
  • MaterniT21 PLUS
  • NIFTY
  • Panorama
  • PrenaTest
  • verifi
  • VisibiliT
  • Others

Major regions analyzed under this research report are: 

  • Europe
  • North America 
  • Asia Pacific 
  • Rest of the World 

This report gives you access to decisive data such as:

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments

Table of Contents


 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Assumptions

      1.3.2 Sources

              1.3.2.1 Secondary Research

              1.3.2.2 Primary Research

      1.3.3 Models

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2022)

2.2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million)

2.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2022 (Value %)

2.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2022 (Volume %)

 

Chapter 3 Global Non-Invasive Prenatal Testing Market Overview

3.1 Introduction

3.2 Major Chromosomal Aneuploidies and their Incidence Rate

      3.2.1 Down Syndrome

      3.2.2 Edwards Syndrome

      3.2.3 Patau Syndrome

      3.2.4 Turner Syndrome

      3.2.5 Klinefelter Syndrome

      3.2.6 Jacobs Syndrome

      3.2.7 Triple X Syndrome

3.3 Technological Approach for NIPT

3.4 Patent Landscape

      3.4.1 Major Patents issued to Sequenom, Inc.

      3.4.2 Major Patents issued to Ariosa Diagnostics, Inc.

      3.4.3 Major Patents issued to Natera, Inc.

      3.4.4 Major Patents issued to Verinata Health, Inc. (Illumina, Inc.)

      3.4.5 Major Patents issued to Cellscape Corporation

      3.4.6 Others

3.5 Market Drivers

      3.5.1 High incidence rate of babies born with Down syndrome

      3.5.2 Globally rising average maternal age

      3.5.3 Increasing demand for early and non-invasive fetal testing procedures

3.6 Market Restraints

      3.6.1 Regulatory guidelines and ethical hurdles

      3.6.2 Limitations of NIPT

      3.6.3 Availability of other screening and testing methods

3.7 Market Opportunities

      3.7.1 Capitalizing on the potential presented by the emerging markets of Asia

3.8 Porter’s Five Force Analysis: Global Non-Invasive Prenatal testing Market

      3.8.1 Bargaining power of suppliers

      3.8.2 Bargaining power of buyers

      3.8.3 Threat of substitutes

      3.8.4 Threat of new entrants

      3.8.5 Competitive rivalry

3.9 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

      3.9.1 Market Attractive Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

3.10 Competitive Landscape

      3.10.1 Market Share Analysis, by Key Players, 2013 (%)

      3.10.2 Non-Invasive Prenatal Testing: Market Share, by Key Players, 2013(%)

 

Chapter 4 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Test

4.1 Overview

      4.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2022 (USD Million)

      4.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Test, 2012 – 2022 (Number of Tests Performed)

      4.1.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2013 & 2022 (Value %)

      4.1.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Test, 2013 & 2022 (Volume %)

4.2 BambniTest

      4.2.1 Global BambniTest Test Market Revenue, 2012 – 2022 (USD Million)

      4.2.2 Global BambniTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.3 Harmony Prenatal Test

      4.3.1 Global Harmony Test Market Revenue, 2012 – 2022 (USD Million)

      4.3.2 Global Harmony Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.4 informaSeq Prenatal Test

      4.4.1 Global informaSeq Test Market Revenue, 2014 – 2022 (USD Million)

      4.4.2 Global informaSeq Test Market Volume, 2014 – 2022 (Number of Tests Performed)

4.5 MaterniT21 PLUS

      4.5.1 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2022 (USD Million)

      4.5.2 Global MaterniT21 PLUS Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.6 Non-invasive Fetal Trisomy (NIFTY) Test

      4.6.1 Global NIFTY Test Market Revenue, 2012 – 2022 (USD Million)

      4.6.2 Global NIFTY Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.7 Panorama Test

      4.7.1 Global Panorama Test Market Revenue, 2012 – 2022 (USD Million)

      4.7.2 Global Panorama Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.8 PrenaTest

      4.8.1 Global PrenaTest Test Market Revenue, 2012 – 2022 (USD Million)

      4.8.2 Global PrenaTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.9 verifi

      4.9.1 Global verifi Test Market Revenue, 2012 – 2022 (USD Million)

      4.9.2 Global verifi Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.10 VisibiliT Test

      4.10.1 Global VisibiliT Test Market Revenue, 2014 – 2022 (USD Million)

      4.10.2 Global VisibiliT Test Market Volume, 2014 – 2022 (Number of Tests Performed)

4.11 Others

      4.11.1 Global Other Tests Market Revenue, 2014 – 2022 (USD Million)

      4.11.2 Global Other Tests Market Volume, 2014 – 2022 (Number of Tests Performed)

 

Chapter 5 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Geography

5.1 Overview

      5.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

      5.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2012 – 2022 (Number of Tests Performed)

5.2 North America

      5.2.1 North America Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.2.2 North America Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

5.3 Europe

      5.3.1 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.3.2 Europe Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

5.4 Asia-Pacific

      5.4.1 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.4.2 Asia-Pacific Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

5.5 Rest of the World (RoW)

      5.5.1 RoW Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.5.2 RoW Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

 

Chapter 6 Recommendations

6.1 Focus on improving technology in order to increase the accuracy, reduce the duration of result generation and price

6.2 Focus on forming alliances with diagnostic service providers in Latin American and Asia-Pacific countries

6.3 Mergers and acquisitions

 

Chapter 7 Company Profiles

7.1 Ariosa Diagnostics, Inc.

      7.1.1 Company Overview

      7.1.2 Financial Overview

      7.1.3 Product Portfolio

      7.1.4 Business Strategies

      7.1.5 Recent Developments

7.2 Berry Genomics Co., Ltd.

      7.2.1 Company Overview

      7.2.2 Financial Overview

      7.2.3 Product Portfolio

      7.2.4 Business Strategies

      7.2.5 Recent Developments

7.3 BGI Diagnostics

      7.3.1 Company Overview

      7.3.2 Financial Overview

      7.3.3 Product Portfolio

      7.3.4 Business Strategies

      7.3.5 Recent Developments

7.4 Illumina, Inc.

      7.4.1 Company Overview

      7.4.2 Financial Overview

      7.4.3 Product Portfolio

      7.4.4 Business Strategies

      7.4.5 Recent Developments

7.5 Laboratory Corporation of America Holdings (LabCorp)

      7.5.1 Company Overview

      7.5.2 Financial Overview

      7.5.3 Product Portfolio

      7.5.4 Business Strategies

      7.5.5 Recent Developments

7.6 LifeCodexx AG

      7.6.1 Company Overview

      7.6.2 Financial Overview

      7.6.3 Product Portfolio

      7.6.4 Business Strategies

      7.6.5 Recent Developments

7.7 Natera, Inc.

      7.7.1 Company Overview

      7.7.2 Financial Overview

      7.7.3 Product Portfolio

      7.7.4 Business Strategies

      7.7.5 Recent Developments

7.8 Sequenom, Inc.

      7.8.1 Company Overview

      7.8.2 Financial Overview

      7.8.3 Product Portfolio

      7.8.4 Business Strategies

      7.8.5 Recent Developments

List of Figures

 

FIG. 1 Non-Invasive Prenatal Testing: Market Segmentation

FIG. 2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2022 (Value %)

FIG. 4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2022 (Volume %)

FIG. 5 Porter’s Five Force Analysis: Global Non-Invasive Prenatal Testing Market

FIG. 6 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

FIG. 7 Non-Invasive Prenatal Testing: Market Share, by Key Players, 2013 (%)

FIG. 8 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2013 & 2022 (Value %)

FIG. 9 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Test, 2013 & 2022 (Volume %)

FIG. 10 Global BambniTest Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 11 Global BambniTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 12 Global Harmony Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 13 Global Harmony Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 14 Global informaSeq Test Market Revenue, 2014 – 2022 (USD Million)

FIG. 15 Global informaSeq Test Market Volume, 2014 – 2022 (Number of Tests Performed)

FIG. 16 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 17 Global MaterniT21 PLUS Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 18 Global NIFTY Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 19 Global NIFTY Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 20 Global Panorama Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 21 Global Panorama Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 22 Global PrenaTest Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 23 Global PrenaTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 24 Global verifi Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 25 Global verifi Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 26 Global VisibiliT Test Market Revenue, 2014 – 2022 (USD Million)

FIG. 27 Global VisibiliT Test Market Volume, 2014 – 2022 (Number of Tests Performed)

FIG. 28 Global Other Tests Market Revenue, 2014 – 2022 (USD Million)

FIG. 29 Global Other Tests Market Volume, 2014 – 2022 (Number of Tests Performed)

FIG. 30 North America Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022     (USD Million)

FIG. 31 North America Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 32 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 33 Europe Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 34 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 35 Asia-Pacific Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 36 RoW Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 37 RoW Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 38 LabCorp: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 39 Sequenom, Inc.: Annual Revenue, by Segment, 2011 – 2013 (USD Million)

List of Tables

 

TABLE 1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2022)

TABLE 2 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2022 (USD Million)

TABLE 3 Global Non-Invasive Prenatal Testing Market Volume, by Test, 2012 – 2022 (Number of Tests Performed)

TABLE 4 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

TABLE 5 Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2012 – 2022 (Number of Tests Performed)

TABLE 6 Ariosa Diagnostics, Inc.: Expenses & Revenue, 2011 – 2013 (USD Thousand)

TABLE 7 Sequenom, Inc.: Expenses & Revenue, 2011 – 2013 (USD Million)

Free Market Analysis


 

Non-invasive prenatal testing is increasingly being adopted by high-risk pregnant women for screening common fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X). Non-invasiveness, accuracy, and safety are the major factors attributed to the popularity of these tests among gynecologists and expecting mothers compared to invasive tests such as chorionic villus sampling (CVS) and amniocentesis. MaterniT21 (now known as MaterniT21 PLUS) was the first NIPT launched in October 2011 by U.S.-based Sequenom, Inc. Since then, it has led the market, accounting for the largest share in terms of revenue as well as volume (number of tests performed in a year). However, BGI’s NIFTY is expected to outperform MaterniT21 PLUS in terms of volume in the global market by the end of 2014. Sequenom, Inc. is likely to maintain its leadership position in North America through 2022. Harmony, verifi, Panorama, informaSeq, VisibiliT, PrenaTest, and BambniTest are the other commercially available NIPTs for detecting chromosomal abnormalities. 

 

The exponential growth of the NIPT market is supported by factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT, and shifting trend toward child bearing at advanced maternal age (35 years or older). Maternal age is closely associated with the risk of developing a fetus with chromosomal abnormalities; hence, rising maternal age is likely to contribute to the increasing incidence of babies born with chromosomal aneuploidies. According to Down Syndrome Education (DSE), the incidence rate for Down syndrome is one in every 830 child births (around 4,700 annually) in the U.S., while the incidence rate is one in every 920 babies born (around 9,000 annually) in Europe, indicating a large potential consumer base for NIPT. Conventional invasive prenatal genetic tests such as amniocentesis and chorionic villus sampling (CVS) are associated with the risk of miscarriage; hence, these are being replaced with new non-invasive prenatal tests. These new NIPTs are based on the analysis of cell-free DNA floating in the maternal plasma and pose no risk of miscarriage.

 

North America held the largest share of the global NIPT market in terms of revenue as well as volume in 2013, accounting for 58.8% and 51.0%, respectively, of the market. Major players domiciled in the U.S. and relatively high awareness levels about NIPT in North America are the key factors attributed to the region’s leadership position. In Europe, market growth largely depends upon increasing penetration of these U.S.-based test developers and increase in acceptance of these tests. Japan, Australia, China, and India represent high growth potential markets in Asia-Pacific. Large population of women preferring late pregnancy is likely to act as a major driver of the NIPT market in the region. The NIPT market in China is dominated by two local players: BGI Diagnostics and Berry Genomics. In addition, the recent CFDA approval for BambniTest would propel the growth of the market in this region.

 

Sequenom, Inc., Illumina, Inc. (Verinata Health, Inc.), Ariosa Diagnostics, Natera, Inc., BGI Health, LifeCodexx AG, LabCorp, and Berry Genomics are the key players competing in the non-invasive prenatal testing market. These players operate by marketing their proprietary non-invasive prenatal tests by forming alliances with hospitals, clinical laboratories, and physician offices.
 

 

 


To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Report tailored as you need

If you feel this report needs customization, feel free to contact us. Our team of expert analyst can fulfil your requirements.

CUSTOMIZE REPORT

Upcoming Report

Payment
Copyright @ Transparency Market Research